Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8916 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8683 |
High Similarity |
NPD6797 |
Phase 2 |
0.8675 |
High Similarity |
NPD7054 |
Approved |
0.8631 |
High Similarity |
NPD7251 |
Discontinued |
0.8623 |
High Similarity |
NPD7472 |
Approved |
0.8623 |
High Similarity |
NPD7074 |
Phase 3 |
0.8614 |
High Similarity |
NPD3818 |
Discontinued |
0.858 |
High Similarity |
NPD7808 |
Phase 3 |
0.8466 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8383 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8293 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.825 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8232 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8221 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8199 |
Intermediate Similarity |
NPD1653 |
Approved |
0.814 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8103 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8103 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8092 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8092 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8072 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8061 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8052 |
Intermediate Similarity |
NPD1933 |
Approved |
0.8024 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7989 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7963 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7952 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7911 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7844 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7826 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7821 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7809 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7714 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7657 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7633 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7625 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7546 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7532 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7531 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7515 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7514 |
Intermediate Similarity |
NPD5494 |
Approved |
0.75 |
Intermediate Similarity |
NPD6779 |
Approved |
0.75 |
Intermediate Similarity |
NPD6781 |
Approved |
0.75 |
Intermediate Similarity |
NPD6776 |
Approved |
0.75 |
Intermediate Similarity |
NPD6780 |
Approved |
0.75 |
Intermediate Similarity |
NPD6778 |
Approved |
0.75 |
Intermediate Similarity |
NPD1091 |
Approved |
0.75 |
Intermediate Similarity |
NPD6782 |
Approved |
0.75 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7473 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD37 |
Approved |
0.747 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7442 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7442 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7442 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7429 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7421 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7401 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7377 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7375 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7698 |
Approved |
0.729 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7262 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD919 |
Approved |
0.7256 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7254 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7247 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.724 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7231 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD9717 |
Approved |
0.72 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7198 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7195 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7191 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7165 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7165 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7125 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7121 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7121 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7121 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7081 |
Intermediate Similarity |
NPD411 |
Approved |
0.7079 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7056 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD2798 |
Approved |
0.703 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7006 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD9494 |
Approved |
0.6994 |
Remote Similarity |
NPD1240 |
Approved |
0.6994 |
Remote Similarity |
NPD943 |
Approved |
0.6983 |
Remote Similarity |
NPD1247 |
Approved |
0.6981 |
Remote Similarity |
NPD2797 |
Approved |
0.6979 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6976 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD3268 |
Approved |
0.697 |
Remote Similarity |
NPD7585 |
Approved |
0.6937 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6919 |
Remote Similarity |
NPD7583 |
Approved |
0.6911 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6911 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6911 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6909 |
Remote Similarity |
NPD1607 |
Approved |
0.6907 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.689 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6885 |
Remote Similarity |
NPD2163 |
Approved |
0.6883 |
Remote Similarity |
NPD9493 |
Approved |
0.6867 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6853 |
Remote Similarity |
NPD7680 |
Approved |
0.6839 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6829 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6826 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6821 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6821 |
Remote Similarity |
NPD6273 |
Approved |
0.6818 |
Remote Similarity |
NPD6386 |
Approved |
0.6818 |
Remote Similarity |
NPD6385 |
Approved |
0.681 |
Remote Similarity |
NPD7095 |
Approved |
0.68 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6798 |
Remote Similarity |
NPD5353 |
Approved |
0.6793 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6792 |
Remote Similarity |
NPD1608 |
Approved |
0.6786 |
Remote Similarity |
NPD6099 |
Approved |
0.6786 |
Remote Similarity |
NPD6100 |
Approved |
0.6784 |
Remote Similarity |
NPD2354 |
Approved |
0.6784 |
Remote Similarity |
NPD3887 |
Approved |
0.6774 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6769 |
Remote Similarity |
NPD4420 |
Approved |
0.6768 |
Remote Similarity |
NPD3764 |
Approved |
0.6765 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6765 |
Remote Similarity |
NPD7930 |
Approved |
0.6763 |
Remote Similarity |
NPD4662 |
Approved |
0.6763
|
Remote Similarity |
NPD2533 |
Approved |